THE HEALTHCARE & SCIENCE BUSINESS OF THOMSON REUTERS ACCELERATING R&D and INNOVATION Keith MacGregor Executive Vice President November 12, 2010
THOMSON REUTERS MARKETS DIVISION PROFESSIONAL DIVISION Sales & Trading Investment & Advisory Enterprise Media Legal Healthcare & Science Tax & Accounting Information trading for buy/sell side Information/ software for capital markets Decision support, portfolio mgr, investment banking Global news services Legal, professional & government, professionals Researchers, scientists, healthcare professionals, academic & government Tax, accounting, compliance, professional & government Thomson Reuters at a glance: 2009 Revenue: US $12.9billion Employees: 50,000 Operations: 100 countries 2
THE HEALTHCARE & SCIENCE BUSINESS OF THOMSON REUTERS Intelligent information to better manage the cost and quality of healthcare and accelerate scientific research and innovation. 3
THOMSON REUTERS OPERATING PRINCIPLES INTELLIGENT INFORMATION DIFFERENTIATED OFFERINGS DATA YOU CAN TRUST Human intelligence, industry expertise, and innovative technology to provide decision makers with the knowledge to act Unique, derived content, added-value capabilities, and powerful comprehensiveness make us a valued partner We are committed to delivering reliable data of the highest quality with roundthe-clock support, whenever you may need us BREADTH AND DEPTH INDEPENDENT & OBJECTIVE QUALITY Widely recognized as offering the broadest coverage of data across the globe Our focus is providing you with only the highest caliber data free from bias to give you a trusted resource of intelligent information Our editorial standards are unparalleled in the industry, providing you with only the very best information for confident decisions 4
SCIENCE MARKETS IP SOLUTIONS Accelerating innovation in high tech industries, including engineering, automotive and aerospace SCIENTIFIC & SCHOLARLY RESEARCH Accelerating research at more than 5,000 research institutions, including national and regional consortia LIFE SCIENCES Accelerating discovery in 98 of the top 100 pharmaceutical companies
OUR PURPOSE : Accelerate research, discovery and innovation Serving needs of researchers for quality, authoritative and timely information Discovery and research assessment tools for scientists to accelerate and optimize their research Comprehensive intellectual property research and management solutions Accelerate innovation while minimizing risk Gain competitive advantage with actionable intelligence Maximize R&D investments Drug discovery and support information tools for every stage of the drug development life cycle helping to get to market faster We create the research platforms and services of the future that will power our customers toward business and personal success. 6
SCIENTIFIC & SCHOLARLY RESEARCH COMPETITION FOR RESEARCH FUNDING IS FIERCE ACROSS THE GLOBE, WE VE GOT THE TOOLS TO HELP YOU SUCCEED. 7
LIFE SCIENCES WITH AN ESTIMATED COST OF $500 MILLION* TO BRING A DRUG TO MARKET, EVERY DECISION COUNTS. *The Goodwyn Institutional Review Board, Ltd. 8
THOMSON REUTERS IP SOLUTIONS Powering the Intellectual Property Lifecycle with the world s most comprehensive resources PATENTS & STANDARDS TRADEMARKS INTELLIGENT INFORMATION ADVANCED TOOLS & ANALYTICS EXPERT IP SERVICES 9
OUR APPROACH SAMPLE WORKFLOW Understand customer s workflow & work done +/- 3 minutes from our tools Meeting Preparation Meeting & Discussion Online Research Document Sharing Commenting & Annotation Develop strengths that address needs at each step prior and after interaction with our solutions 10
SUPPORTING THE IP LIFECYCLE Market Awareness Filing Strategy Drive innovation Protect intellectual assets Create maximum value from their ideas 11
THE SPEED OF INNOVATION As the pace of innovation increases, companies are looking for new ways to decrease their time to market. Stimulate new product ideas Make smart build vs. buy decisions Clear trademarks for use more quickly 12
THANK YOU